Detection method for fingerprint spectrum of pyretic-clearing and lung-protecting granules

By establishing a fingerprint spectrum detection method for Qingwen Hufeng granules, the quality control problem of traditional Chinese medicine compound preparations has been solved, and the efficient separation and quantitative analysis of key components have been achieved, thereby improving the accuracy and stability of product quality control.

CN118937515AActive Publication Date: 2024-11-12SHAANXI ACAD OF TRADITIONAL CHINESE MEDICINE

Patent Information

Application Number
CN202410987170.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12
Estimated Expiration
2044-07-23

AI Technical Summary

Technical Problem

Existing quality control methods for Qingwen Hufeng Granules, a traditional Chinese medicine compound preparation, are insufficient to fully reflect its intrinsic quality. Thin-layer chromatography cannot adequately control the overall characteristics of the traditional Chinese medicine compound, making it difficult to guarantee quality consistency and stability.

Method used

A fingerprint chromatographic detection method for Qingwen Hufeng Granules was established using high performance liquid chromatography-mass spectrometry (HPLC-MS). Fourteen common chromatographic peaks were identified and seven key components were identified, including neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythoside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid, and angoloside C. High efficiency separation and quantitative analysis of the components were achieved through gradient elution and optimized chromatographic conditions.

Benefits of technology

This technology enables efficient separation and quantitative detection of key components in Qingwen Hufeng Granules, improving the accuracy and stability of quality control, ensuring the consistency and safety of the product's intrinsic quality, and reducing testing costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937515A_ABST
    Figure CN118937515A_ABST
Patent Text Reader

Abstract

The invention provides a detection method of a fingerprint spectrum of granules capable of clearing heat and protecting lung. According to the detection method, 14 common chromatographic peaks are determined in total in a generated standard fingerprint spectrum. According to the fingerprint detection method established by the invention, 14 batches of antipyretic and lung-protecting particles are measured, and the similarity value is greater than or equal to 0.943. The invention also establishes a method for determining the content of seven index components including neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3, 5-O-dicaffeoylquinic acid, 4, 5-dicaffeoylquinic acid and anagloside, methodological results show that the precision, stability and sample recovery rate are good, and the method is suitable for industrial production. The method can be used for detecting and identifying the internal quality of the traditional Chinese medicine composition of the antipyretic and lung-protecting granules, and has a good market prospect in industrial large-scale production and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of quality detection of chemical components of traditional Chinese medicine, and in particular relates to a detection method for the fingerprint spectrum of Qingwen Hufei granules. Background Art

[0002] Qingwen Hufei Granules are composed of 16 Chinese medicinal herbs including honeysuckle, forsythia, Fritillaria thunbergii, isatis indigotica, loblolly, platycodon, codonopsis pilosula, stir-fried atractylodes, poria, scrophularia, ophiopogon japonicus, bitter almond, capillaris, saposhnikovia divaricata, perilla leaf, and licorice. It has the effects of relieving wind-heat, clearing the lungs and relieving cough, and protecting the spleen and stomach. It is suitable for mild cases of new coronavirus infection and acute respiratory tract infections in winter and spring.

[0003] The applicant has filed two related patent applications for this product, specifically CN111097021A, which discloses a Chinese medicine composition for treating mild COVID-19, suspected COVID-19 patients and acute respiratory tract infections. The Chinese medicine composition is made of the following Chinese medicine raw materials in parts by weight: 10-20g of honeysuckle, 10-20g of forsythia, 10-20g of isatis indigotica, 10-20g of scrophularia, 6-15g of stir-fried bitter almonds, 10-20g of thunbergii, 6-15g of platycodon grandiflorum, and 10-20g of purple purpurogenous rice. Perilla leaf 6-15g, Saposhnikovia divaricata 6-15g, bran-fried Atractylodes macrocephala 10-20g, Poria cocos 10-20g, Artemisia capillaris 10-20g, Codonopsis pilosula 10-20g, Bamboo leaf 6-15g, Ophiopogon japonicus 10-20g, Raw Licorice root 4-10g; the preparation method of stir-fried bitter almond is to stir-fry bitter almond; the preparation method of stir-fried Atractylodes macrocephala is to heat raw Atractylodes macrocephala and then stir-fry with wheat bran; take the above-mentioned Chinese medicine raw materials by weight, decoct in water for 30 minutes, and take 400ML of juice. The medicine has the characteristics of treating both the exterior and the interior, clearing and replenishing at the same time, and preventing the disease from changing. It has a definite effect on the treatment of respiratory infections in winter and spring. The symptoms improved before and after taking the medicine are runny nose, fever, cough, dry throat and sore throat, expectoration, poor diet, and shortness of breath.

[0004] Its publication number CN202211478410.8 records an ultra-high performance liquid chromatography-mass spectrometry detection method for Qingwen Hufei granules. Using ultra-high performance liquid chromatography-quadrupole / electrostatic field orbital trap high-resolution mass spectrometry UHPLC-QExactiveFocusMS / MS technology, a total of 17 terpenoid compounds (including broken oxidized strychnine, broken strychnine acid and other components) and 28 phenylpropanoid compounds (1-O-caffeoylquinic acid, chlorogenic acid, The detection method of the present invention can quickly separate and identify the chemical components in Qingwen Hufei granules online, and provide a scientific basis for the research on the material basis of its efficacy.

[0005] However, because Qingwen Hufei Granules is a traditional Chinese medicine compound preparation, the traditional Chinese medicine formula contains a variety of traditional Chinese medicine flavors, and the effective ingredients of traditional Chinese medicine it contains are very complex. The current internal control standards only include the thin layer identification method, but because thin layer identification is a qualitative identification, it cannot fully control the intrinsic quality of the traditional Chinese medicine compound. The fingerprint of traditional Chinese medicine can more comprehensively reflect the overall characteristics of the chemical components of traditional Chinese medicine, and is an effective method for evaluating the authenticity, quality, consistency and stability of traditional Chinese medicine. Combining the multi-index component quantification method with the fingerprint spectrum can provide qualitative and quantitative information of traditional Chinese medicine at the same time, which is an effective quality control method for traditional Chinese medicine. Summary of the invention

[0006] The present invention provides a detection method for the fingerprint of Qingwen Hufei granules. The detection method generates a standard fingerprint and determines a total of 14 common chromatographic peaks, and identifies 7 of the chromatographic peaks, including neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid, and angloside index components. In addition, the fingerprint detection method established by the present invention is used to measure 14 batches of Qingwen Hufei granules, and the similarity value is ≥0.943. The present invention also establishes a method for determining the content of 7 index components of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid, and angloside. The methodological results show that the precision, stability, and sample recovery rate are good, and the method can be used for the intrinsic quality detection and identification of the Qingwen Hufei granule Chinese medicine composition, and has a good market prospect in industrial large-scale production applications.

[0007] The technical solution of the patent application of this invention is:

[0008] A fingerprint spectrum detection method for Qingwen Hufei granules, the detection method comprising the following steps:

[0009] (1) Preparation of the test solution: weigh the Qingwen Hufei granules of the present invention, add methanol to dissolve, ultrasonicate, cool, shake well, filter, evaporate to dryness, fix volume, filter, and take the filtrate to obtain;

[0010] (2) Preparation of reference solution: weigh the reference substances of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-caffeoylquinic acid and angloside C, dilute with 40-60% methanol and make up to volume;

[0011] ⑶、Chromatographic conditions: Chromatographic column is C 18 , mobile phase: 0.1% formic acid water as mobile phase A, acetonitrile as mobile phase B; the present invention adopts a gradient elution method, and the elution order is: 0-14min, 6%-8% B; 14-15min, 8%-13% B; 15-17min, 13%-15% B; 17-20min, 15%-17% B; 20-23min, 17%-33% B; 23-27min, 33% B; 27-31min, 33%-98% B; flow rate 0.2-0.6mL / min; column temperature 23-28°C, detection wavelength 220-270nm;

[0012] (⑷) Establish fingerprint: Determine the test solution in step (1) and the reference solution in step (2) using the chromatographic conditions under step (3), perform detection according to the chromatographic conditions under step (3), sample and analyze multiple batches of Qingwen Hufei Granule test solutions, convert the data file into "AIA" format, import it into the "Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System", and generate a reference fingerprint.

[0013] As a preferred embodiment of the present invention, in step (1) of the detection method, the ultrasonic frequency is 40-60kHz, the ultrasonic power is 280-320W, and the ultrasonic treatment time is 20-40min.

[0014] As a preferred embodiment of the present invention, the concentration of methanol in step (2) of the detection method is 50%.

[0015] As a preferred embodiment of the present invention, in step (2) of the detection method, the concentration of neochlorogenic acid is: 0.0467-0.280 mg / mL, the concentration of chlorogenic acid is: 0.0375-0.2250 mg / mL, the concentration of cryptochlorogenic acid is: 0.0395-0.2370 mg / mL, the concentration of forsythiaside A is: 0.0448-0.2688 mg / mL, the concentration of 3,5-O-dicaffeoylquinic acid is: 0.00506-0.03036 mg / mL, the concentration of 4,5-caffeoylquinic acid is: 0.00396-0.02376 mg / mL, and the concentration of angloside C is: 0.00576-0.03456 mg / mL.

[0016] As a preferred embodiment of the present invention, in step (2) of the detection method, the concentration of neochlorogenic acid is 0.2802 mg / mL, the concentration of chlorogenic acid is 0.2250 mg / mL, the concentration of cryptochlorogenic acid is 0.2370 mg / mL, the concentration of forsythiaside A is 0.1344 mg / mL, the concentration of 3,5-O-dicaffeoylquinic acid is 0.03036 mg / mL, the concentration of 4,5-caffeoylquinic acid is 0.02376 mg / mL, and the concentration of angloside C is 0.03456 mg / mL.

[0017] As the preferred embodiment of the present invention, the detection method step (3) chromatographic column C 18 Model: Agilent ZORBAXEclipse Plus, column specifications: 250mm×4.6mm, 5μm.

[0018] As a preferred embodiment of the present invention, in step (3) of the detection method, the chromatographic column temperature is 25° C., the flow rate is 0.3 mL / min, and the detection wavelength is 254 nm.

[0019] The multiple batches are more than 10 batches.

[0020] As a preferred embodiment of the present invention, the chromatographic conditions of step (3) are used to detect the test solution of the Chinese medicine for clearing away heat and protecting the lungs, and the generated HPLC peak is compared with the control fingerprint spectrum, and the similarity is calculated to be 0.94 to 1.00.

[0021] As a preferred embodiment of the present invention, the detection method can be used in the quality detection and component identification of the Qingwen Hufei Granules Chinese medicine.

[0022] In order to further illustrate the creativity of the detection method of the fingerprint spectrum of Qingwen Hufei granules of the present invention, some experimental contents screened by the technical scheme of the present invention are summarized as follows.

[0023] In the process of establishing the fingerprint method of the present invention, the best chromatographic conditions were obtained after repeated experiments. This is mainly because the preparation process of the Qingwen Hufei Granules of the present invention is a traditional water extraction process, with a large prescription (containing 16 Chinese medicines), but the proportion of a single medicine is relatively small (the total prescription is 206g, and 10 medicines such as honeysuckle and forsythia are all 15g, which are the largest medicinal materials in the prescription, that is, the largest medicinal material accounts for only 7.3%). The above multiple reasons have caused the following problems in the Qingwen Hufei Granules product: (1) The ingredients are complex and the chromatographic peaks are not easy to separate; (2) The content of each component is low and it is not easy to quantify; (3) The peak height is low and the baseline is not easy to stabilize. The method described in this article can separate chromatographic peaks well under a large number of chromatographic conditions. In addition, it has the following advantages: (1) Standards are easily available and inexpensive, which reduces the cost for quality control; (2) The detection time is shortened (in the process of exploration, the separation is good at about 130 minutes. Considering the long time, the conditions are optimized and compressed to 100 minutes), which improves the detection efficiency for quality control; (3) The reagents in the detection method of the present invention are consumables that are easily available and inexpensive, harmless to humans and the environment, and meet environmental protection requirements; (4) The chromatographic conditions are simple and the separation is good, which reduces the detection cost for quality control while ensuring accuracy.

[0024] The specific process is as follows:

[0025] 1.1 Optimization of chromatographic conditions

[0026] Different types of mobile phases (methanol-water, methanol-0.1% phosphoric acid, acetonitrile-0.1% phosphoric acid, methanol-0.1% formic acid) and proportions, as well as detection wavelengths (220, 230, 250, 270, 290, 310, 330 nm) were investigated, and their effects on the number of chromatographic peaks, area, peak shape, separation and baseline stability were analyzed. Finally, the Agilent ZORBAX EclipsePlus-C18 column was selected, with methanol-0.1% phosphoric acid aqueous solution by volume as the mobile phase, and detection and separation were carried out at a wavelength of 330 nm.

[0027] 1.2 Investigation of the preparation method of the test solution

[0028] Based on the comprehensive evaluation basis of chromatographic peak information richness, peak shape and relative peak area, the effects of different extraction solvents (methanol with volume fractions of 50%, 70% and 100%, respectively), ultrasonic time (30, 45, 60 min) and solvent after evaporation (water, methanol, 50% methanol) on the extraction effect of the measured components were investigated. Finally, it was determined to use 100% methanol by volume as the solvent and ultrasonic extraction for 30 minutes.

[0029] 1.3 Optimization of chromatographic mobile phase conditions

[0030] Due to the complex chemical components contained in Qingwen Hufei Granules and the obvious difference in polarity, it is difficult to achieve effective separation and analysis by simply relying on isocratic elution, so gradient elution is adopted to achieve the effect of improving peak shape and increasing separation degree. This application uses methanol (A)-0.1% phosphoric acid solution (B) for elution. In the early stage, during 2-15 minutes, only Peak 1 exists. This application accelerates the growth ratio of methanol in the mobile phase to shorten the elution time between the two and reduce the overall duration; at about 12-40 minutes, a gradient elution method is used to separate the new chlorogenic acid of Peak 2, chlorogenic acid of Peak 3, and cryptochlorogenic acid of Peak 5 in Qingwen Hufei Granules; because Peaks 6-10 are all unknown peaks in Peaks 6-12, and Peak 8 is preceded and followed by interference peaks, so the methanol ratio is quickly increased in 35-38 minutes, and the methanol ratio is slowly increased in 38-80 minutes to separate Peaks 6-12. Rapidly increasing the methanol ratio will greatly shorten the analysis time, but it is worth noting that if the ratio increases too rapidly, the baseline will also shift upward, which will have a huge impact on the subsequent chromatographic peaks. Therefore, after a large number of experiments, this application found a suitable methanol growth ratio; Peak 11, Forsythiaside A, and Peak 12, 3,5-O-dicaffeoylquinic acid, were too close in polarity to be separated using isocratic separation, so they were separated by reducing the flow rate, changing the overall flow rate from 1ml / min to 0.8ml / min, and successfully separating Peaks 11 and 12; at 80-100min, there were only two control peaks, No. 13 and No. 14, and there was an interference peak next to Peak 13. Considering the long overall time, the methanol ratio was still changed rapidly. After a lot of experimental exploration and proportion adjustment, the optimal mobile phase ratio was determined to be 0-12 min, 10%-16% A; 12-35 min, 16%-18% A; 35-38 min, 18%-30% A; 38-80 min, 30%-34% A; 80-95 min, 34%-58% A; 95-100 min, 58%-90% A.

[0031] 1.4 Selection of indicator components

[0032] The fingerprint spectrum was compared with the reference substance and identified 15 peaks, namely neochlorogenic acid (peak 2), chlorogenic acid (peak 3), cryptochlorogenic acid (peak 5), forsythiaside A (peak 11), 3,5-O-dicaffeoylquinic acid (peak 12), 4,5-dicaffeoylquinic acid (peak 13), and angoside C (peak 14).

[0033] After consulting relevant literature reports, we know that the organic acid components in honeysuckle can inhibit the overexpression of interferon β (IFN-β) or the secretion of NO, IL-6, IL-1β, and TNF-α in inflammatory cells to fight inflammation; forsythiaside A in forsythia can also reduce the production of cellular inflammatory factors, such as inhibiting the expression of STAT3 protein by upregulating miR-124, thereby inhibiting the production of 1L-6 and exerting its anti-inflammatory effect; the water extract of Scrophularia can promote the growth of mouse immune organs and carbon clearance index, improve the content of mouse serum hemolysin and IFN-γ, and play an immunomodulatory role. Therefore, these 7 components are included in the index components of the content determination of Qingwen Hufei granules.

[0034] In this experiment, an HPLC method was established to simultaneously determine the contents of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid, and angoside C in Qingwen Hufei granules. This content detection method is accurate, precise, and simple, which helps to improve the quality control level of the preparation and ensure its effectiveness and safety in clinical application.

[0035] The beneficial effects of the patented technical solution of this invention are as follows:

[0036] ⑴. After a lot of experimental explorations, the present invention finally found the optimal chromatographic conditions for the fingerprint of Qingwen Hufei granules. Agilent ZORBAX Eclipse Plus-C18 chromatographic column (250mm×4.6mm, 5μm); mobile phase methanol (A), 0.1% phosphoric acid (B), gradient elution (0-12min, 10%-16% A; 12-35min, 16%-18% A; 35-38min, 18%-30% A; 38-80min, 30%-34% A; 80-95min, 34%-58% A; 95-100min, 58%-90% A); volume flow rate 0.8mL / min; column temperature 30℃; detection wavelength 330nm.

[0037] After methodological investigation, the results of the repeatability test showed that the relative standard deviation (RSD) of the relative retention time of each common peak was 0.019% to 0.637%, and the RSD of the relative peak area was 0.049% to 0.596%, indicating that the injection repeatability was good. The results of the repeatability test showed that the RSD of the relative retention time of each common peak was 0.004% to 0.082%, and the RSD of the relative peak area was 0.062% to 2.520%, indicating that the method had good repeatability. The results of the stability test showed that the RSD of the relative retention time of each common peak was 0.006% to 0.142%, and the RD of the relative peak area was 0.210% to 3.066%, indicating that the test sample of the present invention was stable within 24 hours at room temperature.

[0038] Similarity analysis of the fingerprints of the present invention: the similarities of 14 batches of Qingwen Hufei granules were 0.972, 0.984, 0.992, 0.992, 0.983, 0.981, 0.992, 0.993, 0.943, 0.996, 0.996, 0.997, 0.949 and 0.996, respectively, which also shows that the quality of Qingwen Hufei granules in different batches is relatively stable.

[0039] ⑵. The detection method of the present invention generates a standard fingerprint spectrum, determines a total of 14 common chromatographic peaks, and identifies 7 of them, including neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid, and angoside index components. The above detection method can be used for the intrinsic quality detection and component identification of Qingwen Hufei Granules, providing a new reference basis.

[0040] ⑶. The present invention establishes an HPLC method to simultaneously determine the contents of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid, and angoside C in Qingwen Hufei granules. The methodological validation results show that the results of the injection repeatability test show that the peak area RSDs of each component are 0.10% for neochlorogenic acid, 0.06% for chlorogenic acid, 0.14% for cryptochlorogenic acid, 0.14% forsythiaside A, 0.43% for 3,5-O-dicaffeoylquinic acid, 0.03% for 4,5-O-dicaffeoylquinic acid, and 0.08% for angoside C, indicating that the injection repeatability is good. The results of the stability test showed that the RSD of the peak area of ​​each component was 0.35% for neochlorogenic acid, 0.16% for chlorogenic acid, 0.10% for cryptochlorogenic acid, 0.25% forsythiaside A, 1.82% for 3,5-O-dicaffeoylquinic acid, 2.04% for 4,5-O-dicaffeoylquinic acid, and 0.38% for angloside C, indicating that the solution had good stability within 24 hours. The results of the repeatability test showed that the RSD of the content of each component was 2.28% for neochlorogenic acid, 2.55% for chlorogenic acid, 2.34% for cryptochlorogenic acid, 1.41% forsythiaside A, 2.14% for 3,5-O-dicaffeoylquinic acid, 2.00% for 4,5-O-dicaffeoylquinic acid, and 1.39% for angloside C, indicating that the method had good repeatability. The results of the sample recovery test showed that the average recoveries of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid and angloside C were 97.67%, 96.31%, 96.46%, 96.94%, 97.39%, 103.84% and 102.45%, respectively, and the RSDs were 1.42%, 0.56%, 1.20%, 1.22%, 0.52%, 0.96% and 0.36%, respectively.

[0041] (4) After multiple batches of content determination, it can be known that the content of neochlorogenic acid in the Qingwen Hufei granules of the present invention is 0.0210-0.0459%, chlorogenic acid 0.0269-0.0506%, cryptochlorogenic acid 0.028-0.0461%, 3,5-O-dicaffeoylquinic acid A 0.0444-0.1045%, forsythiaside A 0.0067-0.0156%, 4,5-O-dicaffeoylquinic acid 0.0088-0.0144%, and angloside C 0.0057-0.0101%. The above detection method can be used as the internal control quality standard of the product to further ensure the intrinsic quality of the product.

[0042] ⑸. There are 14 common peaks in the fingerprints of 14 batches of Qingwen Hufei Granules, with a similarity greater than 0.9. Cluster analysis can divide the 14 batches of samples into 3 categories, and principal component analysis obtains 4 principal components, with a cumulative variance contribution rate of 99.529%. The content determination results show that the average sample recovery rate of the above 7 components is 97.11% to 101.14%, the RSD is 0.60% to 2.65%, and the precision, stability, and repeatability test RSD are all less than 3.0%. The HPLC fingerprint and content determination method established by the present invention are efficient and feasible, with good repeatability, and can be used for the quality control of Qingwen Hufei Granules, providing a reference basis. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] Figure 1 , HPLC fingerprints of 14 batches of Qingwen Hufei granules;

[0044] Figure 2 , HPLC chromatogram of the mixed reference substance, wherein, chromatographic peak 2-neochlorogenic acid; chromatographic peak 3-chlorogenic acid; chromatographic peak 5-cryptochlorogenic acid; chromatographic peak 11-forsythiaside A; chromatographic peak 12-3,5-O-dicaffeoylquinic acid; chromatographic peak 13-4,5-dicaffeoylquinic acid; chromatographic peak 14-angoloside C;

[0045] Figure 3 , the peaks of the HPLC standard fingerprint of Qingwen Hufei Granules, among which, peak 2 is neochlorogenic acid; peak 3-chlorogenic acid; peak 5-cryptochlorogenic acid; peak 11-forsythiaside A; peak 12-3,5-O-dicaffeoylquinic acid; peak 13-4,5-dicaffeoylquinic acid; peak 14-angoloside C; peaks 1, 4, 6 to 10-unknown peaks;

[0046] Figure 4 , Cluster analysis diagram of 14 batches of Qingwen Hufei granules samples;

[0047] Figure 5 , PCA score chart of 14 batches of Qingwen Hufei Granule samples. DETAILED DESCRIPTION

[0048] Unless otherwise defined, the technical terms or scientific terms used in the patent application specification and claims of the present invention shall have the common meanings understood by persons having ordinary skills in the field to which the present invention belongs.

[0049] Example 1 Construction of the fingerprint spectrum method of Qingwen Hufei granules of the present invention

[0050] 1 Materials

[0051] 1.1 Instruments Agilent 1260 high performance liquid chromatograph equipped with VWD detector and Agilent ChemStation workstation (Agilent Corporation, USA); KQ-100 ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); BS210S (accuracy 0.1 mg) and BT25S (accuracy 0.01 mg) electronic analytical balances (Beijing Sartorius Balance Co., Ltd.).

[0052] 1.2 Reagents and drugs

[0053] 14 batches of Qingwen Hufei Granules (Shaanxi Provincial Hospital of Traditional Chinese Medicine, 10g×10 bags / box, batch numbers 20201101, 20210926, 20220101, 20220701, 20221202, 20210715, 20221228, 20210724, 20210929, 20211005, 20211013, 20211226, 20220418, 20220428, 20220506, numbers S1 to S14). Neochlorogenic acid (CHB220328, purity ≥ 98%), chlorogenic acid (CHB231010, purity ≥ 98%), cryptochlorogenic acid (CHB230830, purity ≥ 98%), forsythiaside A (CHB231017, purity ≥ 98%), 3,5-O-dicaffeoylquinic acid (CBH231227, purity ≥ 98%), 4,5-dicaffeoylquinic acid (CHB240104, purity ≥ 98%), and angloside C (CHB240217, purity ≥ 98%), and reference substances were purchased from Chengdu Kroma Biotechnology Co., Ltd. Methanol was chromatographically pure (Thermo Fisher Scientific, USA); the other reagents were analytically pure; water was Wahaha purified water.

[0054] 1.2 Methods and Results

[0055] 1.2.1 Study on the fingerprint of Qingwen Hufei granules

[0056] 1.2.1.1 Chromatographic conditions

[0057] Agilent ZORBAX Eclipse Plus-C18 chromatographic column (250mm×4.6mm, 5μm); mobile phase methanol (A), 0.1% phosphoric acid (B), gradient elution (0-12min, 10%-16%A; 12-35min, 16%-18%A; 35-38min, 18%-30%A; 38-80min, 30%-34%A; 80-95min, 34%-58%A; 95-100min, 58%-90%A); volume flow rate 0.8mL / min; column temperature 30℃; detection wavelength 330nm; injection volume 10μL.

[0058] 1.2.1.2 Preparation of reference solution

[0059] Accurately weigh an appropriate amount of each reference substance, place them in a 10 mL volumetric flask, dilute with 50% methanol and make up to volume to obtain (neochlorogenic acid 0.2802 mg / mL, chlorogenic acid 0.2250 mg / mL, cryptochlorogenic acid 0.2370 mg / mL, forsythiaside A 0.1344 mg / mL, 3,5-O-dicaffeoylquinic acid 0.03036 mg / mL, 4,5-caffeoylquinic acid 0.02376 mg / mL, and angloside C 0.03456 mg / mL).

[0060] 1.2.1.3 Preparation of test solution

[0061] Grind the contents of this product, accurately weigh 2.0g, place in a 50mL stoppered conical flask, dissolve in 30mL methanol, weigh the mass, treat with ultrasound (frequency 50kHz, power 300W) for 30min, cool to room temperature, shake well, filter, evaporate to dryness, and adjust the volume to a 10ml volumetric flask. Filter through a 0.45μm microporous membrane, and take the filtrate to obtain the product.

[0062] 1.2.1.4 Injection repeatability test

[0063] Take the same test solution (batch number 20221228) and inject it continuously for 6 times according to the chromatographic conditions under "1.2.1.1". Take Forsythiaside A (peak 11) as the reference peak, and calculate the relative standard deviation (RSD) of the relative retention time of each common peak, which is 0.019% ~ 0.637%, and the RSD of the relative peak area is 0.049% ~ 0.596%, indicating that the injection repeatability is good.

[0064] 1.2.1.5 Repeatability test

[0065] Take the same batch of Qingwen Hufei Granules (S7), and prepare 6 test solutions in parallel using the method under "2.1.3". The samples were injected separately according to the chromatographic conditions under "2.1.1". Forsythiaside A (peak 11) was used as the reference peak. The RSD of the relative retention time of each common peak was calculated to be 0.004%~0.082%, and the RSD of the relative peak area was 0.062%~2.520%, indicating that this method has good repeatability.

[0066] 1.2.1.6 Stability test

[0067] Take the same sample solution (S7) and measure it at room temperature for 0, 2, 4, 8, 12 and 24 hours according to the chromatographic conditions under "1.2.1.1". Take forsythiaside A (peak 11) as the reference peak, and calculate the RSD of the relative retention time of each common peak to be 0.006%~0.142%, and the RD of the relative peak area to be 0.210%~3.066%, indicating that the sample is stable within 24 hours at room temperature.

[0068] 1.2.1.7 Fingerprint establishment and similarity analysis

[0069] According to the chromatographic conditions under "1.2.1.1", 14 batches of Qingwen Hufei granules were sampled and analyzed, and the data files were converted into "AIA" format and imported into the "Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System (2012 Edition)". S1 was used as the reference spectrum, the time window width was set to 0.3, multi-point calibration and Mark peak matching were performed, and the median method was used to generate the reference fingerprint spectrum. The HPLC fingerprint spectrum overlay and reference spectrum of 14 batches of Qingwen Hufei granules are shown in Figure 1 The calculated similarities between samples S1 to S14 and the control fingerprints were 0.972, 0.984, 0.992, 0.992, 0.983, 0.981, 0.992, 0.993, 0.943, 0.996, 0.996, 0.997, 0.949, and 0.996, respectively, indicating that the quality of Qingwen Hufei Granules in different batches was relatively stable.

[0070] 1.3 Cluster Analysis (CA):

[0071] The peak areas of 14 common peaks in 14 batches of Qingwen Hufei granules were imported into SPSS27 software, and the plot was drawn by intergroup connection and squared Euclidean distance method. The results are shown in the attached Figure 4 The 14 batches of Qingwen Hufei granules samples can be divided into three categories. The first category includes samples S1-2, S5-6, S10-S12, and S14; the second category includes samples S9 and S13; and the third category includes samples S3-4 and S7-8.

[0072] 1.4 Principal Component Analysis (PCA):

[0073] The peak areas of 14 common peaks in 14 batches of Qingwen Hufei granules were imported into SPSS27 software, and principal component analysis was performed after standardization to obtain a 14-order × 14-order data matrix. Four principal components with eigenvalues ​​> 1 were extracted, and the cumulative variance contribution rate was 99.529%, which can reflect the main information of the fingerprint of Qingwen Hufei granules samples, as shown in Table 1. The higher contribution rates of the first principal component are chromatographic peaks 2, 3, 5, 10, 12, and 13, the higher contribution rates of the second principal component are chromatographic peak 4, the higher contribution rates of the third principal component are chromatographic peak 6, and the higher contribution rates of the fourth principal component are chromatographic peaks 4 and 7, as shown in Table 2. Origin software was used to draw the PCA score diagram, see Appendix Figure 5 , 14 batches of Qingwen Hufei granules samples can be divided into 3 categories. The first category includes samples S1-2, S5-6, S10-S12, and S14. The second category includes samples S9 and S13. The third category includes samples S3-4 and S7-8. The third category is sample S3, which is consistent with the results of cluster analysis.

[0074] Table 1 PCA eigenvalues ​​and variance contribution rates of Qingwen Hufei Granules

[0075]

[0076] Table 2 PCA factor loading matrix of Qingwen Hufei Granules

[0077]

[0078]

[0079] Example 2 Determination of the contents of seven index components in Qingwen Hufei granules

[0080] 2.1.1 Chromatographic conditions

[0081] Agilent ZORBAX Eclipse Plus-C18 chromatographic column (250mm×4.6mm, 5μm); mobile phase methanol (A), 0.1% phosphoric acid (B), gradient elution (0-12min, 10%-16%A; 12-35min, 16%-18%A; 35-38min, 18%-30%A; 38-80min, 30%-34%A; 80-95min, 34%-58%A; 95-100min, 58%-90%A); volume flow rate 0.8mL / min; column temperature 30℃; detection wavelength 330nm; injection volume 10μL.

[0082] 2.2.2 Preparation of reference solution

[0083] Accurately weigh an appropriate amount of each reference substance, place them in a 10 mL volumetric flask, dilute with 50% methanol and make up to volume to obtain (neochlorogenic acid 0.2802 mg / mL, chlorogenic acid 0.2250 mg / mL, cryptochlorogenic acid 0.2370 mg / mL, forsythiaside A 0.1344 mg / mL, 3,5-O-dicaffeoylquinic acid 0.03036 mg / mL, 4,5-caffeoylquinic acid 0.02376 mg / mL, and angloside C 0.03456 mg / mL).

[0084] 2.2.3 Preparation of test solution

[0085] Grind the contents of this product (Qingwen Hufei Granules) finely, accurately weigh 2.0g, place in a 50mL stoppered conical bottle, dissolve in 30mL methanol, weigh the mass, treat with ultrasound (frequency 50kHz, power 300W) for 30min, cool to room temperature, shake well, filter and evaporate to dryness, and adjust the volume to a 10ml volumetric bottle. Filter through a 0.45μm microporous membrane, and take the filtrate to obtain the product.

[0086] 2.2.4 Linear Relationship

[0087] The reference solution prepared under "2.1.2" was diluted step by step with 75% methanol to 6 different appropriate concentrations, and analyzed under the chromatographic conditions under "2.1.1", and the chromatogram and the area of ​​each chromatographic peak were recorded. The standard curve was constructed with the mass concentration of the index component as the horizontal axis (X) and the peak area as the vertical axis (Y), and the regression equation was calculated. The linear relationship of the four index components is shown in Table 3.

[0088] Table 3 Linear regression analysis of 7 index components in Qingwen Hufei granules

[0089]

[0090]

[0091] From the results in Table 3, we can see that the linear concentration range of neochlorogenic acid is 46.7-280.2 μg·mL -1 The linear concentration range of chlorogenic acid is 37.5~225μg·mL -1 The linear concentration range of cryptochlorogenic acid was 39.5-237 μg·mL -1 The linear concentration range of forsythiaside was A44.8~268.8μg·mL -1 The linear concentration range of 3,5-O-dicaffeoylquinic acid was 5.06-30.36 μg·mL -1 The linear concentration range of 4,5-caffeoylquinic acid was 3.96-23.76 μg·mL -1The linear concentration range of angioside C was 5.76-34.56 μg·mL -1 , and the linear correlation coefficients of the above 7 linear indicator components are ≥0.9996.

[0092] 2.2.5 Injection repeatability test

[0093] Take an appropriate amount of the test sample solution and inject it for determination 6 times under the chromatographic conditions of "2.1.1". The determination results are as follows.

[0094] Table 4 Injection repeatability test results

[0095]

[0096] From the experimental results in Table 4, it can be seen that the RSDs of the peak areas of each component were 0.09% for neochlorogenic acid, 0.08% for chlorogenic acid, 0.07% forsythiaside A, 0.07% forsythiaside A, 0.17% for 3,5-O-dicaffeoylquinic acid, 0.07% forsythiaside C, indicating that the injection repeatability was good.

[0097] 2.2.6 Stability test

[0098] Take the same portion of this product (S7) and prepare the test solution according to the method under "2.1.3". Inject and measure at room temperature at 0, 2, 4, 8, 12, and 24 hours under the chromatographic conditions of "2.1.1". The results are shown in Table 5.

[0099] Table 5 Stability test results

[0100]

[0101] From the result table 3, it can be seen that the RSD of the peak area of ​​each component was 0.22% for neochlorogenic acid, 0.15% for chlorogenic acid, 0.10% for cryptochlorogenic acid, 0.25% forsythiaside A, 1.82% for 3,5-O-dicaffeoylquinic acid, 2.04% for 4,5-O-dicaffeoylquinic acid, and 0.38% forsythiaside C, indicating that the solution had good stability within 24 h.

[0102] 2.2.7 Repeatability test

[0103] Take the same portion of this product (S7) and prepare 6 test sample solutions in parallel according to the method in "2.1.3". Inject and measure under the chromatographic conditions in "2.1.1". The results are shown in Table 6.

[0104] Table 6 Repeatability test results

[0105]

[0106]

[0107] As shown in Table 6, the RSDs of the measured contents of each component were 2.28% for neochlorogenic acid, 2.55% for chlorogenic acid, 2.34% for cryptochlorogenic acid, 1.41% forsythiaside A, 2.14% for 3,5-O-dicaffeoylquinic acid, 2.00% for 4,5-O-dicaffeoylquinic acid, and 1.39% forsythiaside C, indicating that the method had good repeatability.

[0108] 2.2.8 Sample recovery test

[0109] Accurately weigh 6 portions of the product (S7) with known content of each component, 1.0 g each, accurately add the reference substance at a level of 100%, prepare the test solution according to the method under "2.1.3", inject and measure under the chromatographic conditions of "2.1.1", and calculate the recovery rate.

[0110] Table 7 Sample recovery test results

[0111]

[0112]

[0113] The results are shown in Table 7. From the results of the sample recovery experiment, it can be seen that the average sample recoveries of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-O-dicaffeoylquinic acid and angloside C are 97.67%, 96.31%, 96.46%, 96.94%, 97.39%, 103.84% and 102.45%, respectively, and the RSDs are 2.98%, 1.15%, 2.44%, 2.55%, 1.05%, 1.87% and 0.70%, respectively.

[0114] 2.2.9 Sample content determination

[0115] Take 14 batches of samples of the Chinese medicine composition of the present invention, prepare the test solution according to the method under "2.1.3", inject and measure under the chromatographic conditions of "2.1.1", and calculate the content of each index component. The results are shown in Table 8.

[0116] Table 8 Content determination results of 14 batches of Qingwen Hufei granules

[0117]

[0118]

[0119] From the results of the above-mentioned Table 8, it can be seen that after multiple batches of content determination, it can be seen that the content of neochlorogenic acid in the Chinese medicine composition (Qingwen Hufei Granules) of the present invention is 0.0210-0.0459%, chlorogenic acid 0.0269-0.0506%, cryptochlorogenic acid 0.028-0.0461%, 3,5-O-dicaffeoylquinic acid A 0.0444-0.1045%, forsythiaside A 0.0067-0.0156%, 4,5-O-dicaffeoylquinic acid 0.0088-0.0144%, and angloside C 0.0057-0.0101%. The upper and lower limits of the content of the above-mentioned active substance components are maintained within a certain level range, thereby putting forward higher requirements for parameter control in the production process, which further guarantees the stability of the intrinsic quality of the product.

[0120] 3.1 Results Analysis

[0121] The fingerprint of Qingwen Hufei Granules was compared with the reference substance and identified 14 peaks, namely neochlorogenic acid (peak 2), chlorogenic acid (peak 3), cryptochlorogenic acid (peak 5), forsythiaside A (peak 11), 3,5-O-dicaffeoylquinic acid (peak 12), 4,5-dicaffeoylquinic acid (peak 13), and angloside C (peak 14). Studies have shown that these compounds have anti-inflammatory, antibacterial and antiviral activities. Forsythiaside A can significantly inhibit the production of LPS-induced inflammatory mediators TNF-α, IL-1β, NO and PGE2, and can also inhibit the activation of NF-κB and Nrf2 / HO-2 signaling pathways, thereby inhibiting the LPS-induced inflammatory response of BV1 microglia and primary microglia. Chlorogenic acid has an inhibitory effect on the in vitro growth of influenza A virus, syncytial virus, Coxsackie B group 3 virus, Coxsackie B group 5 virus, influenza virus subtype 3, parainfluenza virus type IV, etc., has an antiviral effect and effectively relieves lung inflammation, providing 60% and 50% protection against deaths caused by H1N1 and H3N2. Neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, 3,5-O-dicaffeoylquinic acid, angloside C, and 4,5-dicaffeoylquinic acid can reduce inflammatory responses and alleviate lung injury responses by inhibiting the release of nitric oxide (NO) and reducing the levels of IL-1β, IL-6, IL-8, and TNF-α. This shows that these 7 ingredients may be the key medicinal ingredients of Qingwen Hufei Granules for dispelling wind and heat, clearing the lungs and relieving cough.

[0122] The similarity of HPLC fingerprints of 14 batches of Qingwen Hufei Granules samples was greater than 0.9, indicating good consistency in the composition of the components and stable production and preparation process. Cluster analysis and principal component analysis results showed that 14 batches of Qingwen Hufei Granules samples could be divided into three categories, indicating that there were certain differences in the content of components of Qingwen Hufei Granules in different batches.

[0123] In summary, the present invention establishes the HPLC fingerprint of Qingwen Hufei granules and simultaneously determines the contents of 7 components. The method is accurate, precise and simple, which helps to improve the quality control level of the traditional Chinese medicine preparation and can provide a reference for the formulation of its quality standards.

Claims

1. A fingerprint detection method for Qingwen Hufei granules, characterized in that: The detection method comprises the following steps: (1) Preparation of the test solution: weigh the Qingwen Hufei granules of the present invention, add methanol to dissolve, ultrasonicate, cool, shake well, filter, evaporate to dryness, fix volume, filter, and take the filtrate to obtain; (2) Preparation of reference solution: weigh the reference substances of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, forsythiaside A, 3,5-O-dicaffeoylquinic acid, 4,5-caffeoylquinic acid and angloside C, dilute with 40-60% methanol and make up to volume; ⑶、Chromatographic conditions: Chromatographic column is C 18 , mobile phase: 0.1% formic acid water as mobile phase A, acetonitrile as mobile phase B; the present invention adopts a gradient elution method, and the elution order is: 0-14 min, 6%-8% B; 14-15 min, 8%-13% B; 15-17 min, 13%-15% B; 17-20 min, 15%-17% B; 20-23 min, 17%-33% B; 23-27 min, 33% B; 27-31 min, 33%-98% B; flow rate 0.2-0.6 mL / min; column temperature 23-28 ° C, detection wavelength 220-270 nm; (4) Establishing fingerprint: Determine the test solution in step (1) and the reference solution in step (2) using the chromatographic conditions under step (3), perform detection according to the chromatographic conditions under step (3), sample and analyze multiple batches of Qingwen Hufei Granule test solutions, convert the data file into "AIA" format, import it into the "Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System", and generate a reference fingerprint.

2. The detection method according to claim 1, characterized in that: The detection method step (1) comprises the following steps: the ultrasonic frequency is 40-60 kHz, the ultrasonic power is 280-320 W, and the ultrasonic treatment time is 20-40 min.

3. The detection method according to claim 1, characterized in that: The concentration of methanol in step (2) of the detection method is 50%.

4. The detection method according to claim 1, characterized in that: The concentration of neochlorogenic acid in step (2) of the detection method is: 0.0467-0.280 mg / mL, and the concentration of chlorogenic acid is: The concentration of chlorogenic acid is 0.0375-0.2250 mg / mL, the concentration of cryptochlorogenic acid is 0.0395-0.2370 mg / mL, the concentration of forsythiaside A is 0.0448-0.2688 mg / mL, the concentration of 3,5-O-dicaffeoylquinic acid is 0.00506-0.03036 mg / mL, the concentration of 4,5-caffeoylquinic acid is 0.00396-0.02376 mg / mL, and the concentration of angloside C is 0.00576-0.03456 mg / mL.

5. The detection method according to claim 4, characterized in that: In step (2) of the detection method, the concentration of neochlorogenic acid is 0.2802 mg / mL, the concentration of chlorogenic acid is 0.2250 mg / mL, the concentration of cryptochlorogenic acid is 0.2370 mg / mL, the concentration of forsythiaside A is 0.1344 mg / mL, the concentration of 3,5-O-dicaffeoylquinic acid is 0.03036 mg / mL, the concentration of 4,5-caffeoylquinic acid is 0.02376 mg / mL, and the concentration of angloside C is 0.03456 mg / mL.

6. The detection method according to claim 1, characterized in that: The detection method step (3) chromatographic column C 18 Model: Agilent ZORBAX Eclipse Plus, column specifications: 250 mm×4.6 mm, 5μm.

7. The detection method according to claim 1, characterized in that: In step (3) of the detection method, the chromatographic column temperature is 25°C, the flow rate is 0.3 mL / min, and the detection wavelength is 254 nm.

8. The fingerprint detection method according to claim 1, characterized in that: The chromatographic conditions of step (3) are used to detect the test solution of the Chinese medicine for clearing away heat and protecting the lungs, and the generated high performance liquid chromatography peak is compared with the control fingerprint spectrum, and the similarity is calculated to be between 0.94 and 1.

00.

9. The detection method according to claims 1 to 8, characterized in that: The detection method can be used in the quality detection and component identification of the Qingwen Hufei Granules Chinese medicine.

Citation Information

Patent Citations

  • Ultra-high performance liquid chromatography-mass spectrometry detection method for antipyretic and lung-protecting particles

    CN115950972A

  • Content determination method for eight components in ligusticum wallichii and chrysanthemum Shangqing tablet

    CN116242933A

  • Method for determining content of effective components in Lianhua antipyretic capsule

    CN116256437A

  • Establishment method of fingerprint spectrum of apricot and lotus leaf cough syrup

    CN117761197A

Cited By

  • Construction method and application of specific chromatogram of achyranthes aspera throat-clearing mixture

    CN121805485A